Evidence map›Paper›PMID 33804943›Full record

Trial reportMolecules (Basel, Switzerland)2021

Searching for Potential Markers of Glomerulopathy in Urine by HS-SPME-GC×GC TOFMS.

Tomasz Ligor, Joanna Zawadzka, Grzegorz Strączyński, Rosa M González Paredes, Anna Wenda-Piesik, Ileana Andreea Ratiu, Marek Muszytowski

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. CKD Urine Metabolomics: Modern Concepts and Approaches.Pathophysiology : the official journal of the International Society for Pathophysiology · 2023
    Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Tomasz LigorDepartment of Environmental Chemistry and Bioanalytics, Faculty of Chemistry, Nicolaus Copernicus University, 87-100 Toruń, Poland.
Joanna ZawadzkaDepartment of Nephrology, Diabetology and Internal Medicine, Nicolaus Copernicus University, Rydygier Hospital, 87-100 Toruń, Poland.
Grzegorz StrączyńskiUSL Ltd., 43-110 Tychy, Poland.
Rosa M González ParedesDepartment of Analytical Chemistry, Nutrition and Food Sciences, University of Salamanca, 37008 Salamanca, Spain.
Anna Wenda-PiesikDepartment of Plant Growth Principles and Experimental Methods, UTP University of Science and Technology, 85-796 Bydgoszcz, Poland.
Ileana Andreea RatiuInterdisciplinary Centre of Modern Technologies, Nicolaus Copernicus University, 87-100 Toruń, Poland.ORCID 0000-0003-2615-684X
Marek MuszytowskiDepartment of Nephrology, Diabetology and Internal Medicine, Nicolaus Copernicus University, Rydygier Hospital, 87-100 Toruń, Poland.
Nicolaus Copernicus University · PLBydgoszcz University of Science and Technology · PLUniversidad de Salamanca · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Volatile organic compounds (VOCs) exiting in urine are potential biomarkers of chronic kidney diseases. Headspace solid phase microextraction (HS-SPME) was applied for extraction VOCs over the urine samples. Volatile metabolites were separated and identified by means of two-dimensional gas chromatography and time of flight mass spectrometry (GC × GC TOF MS). Patients with glomerular diseases (

Indexed as

Gas Chromatography-Mass SpectrometryBiomarkersFemaleHumansMaleMiddle AgedRenal Insufficiency, ChronicVolatile Organic CompoundsBiomarkersVolatile Organic Compoundscomprehensive two-dimensional gas chromatographykidney diseasesurine analysisvolatile organic compounds

Identifiers

PMID33804943
PMCPMC8036251
OpenAlexW3136872692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.